The use of zebrafish model in prostate cancer therapeutic development and discovery.
Saved in:
| Title: | The use of zebrafish model in prostate cancer therapeutic development and discovery. |
|---|---|
| Authors: | Amawi H; Department of Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, P.O.BOX 566, Irbid, 21163, Jordan. haneen.amawi@yu.edu.jo., Aljabali AAA; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan., Boddu SHS; College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE., Amawi S; Department of Urology and General Surgery, Faculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, 22110, Jordan., Obeid MA; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan., Ashby CR Jr; Department of Pharmaceutical Sciences, St. John's University, Queens, USA., Tiwari AK; Department of Pharmacology and Experimental Therapeutics, The University of Toledo, Toledo, OH, USA. amit.tiwari@utoledo.edu. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Mar; Vol. 87 (3), pp. 311-325. Date of Electronic Publication: 2021 Jan 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
